Screening and management of maternal colonization with Streptococcus agalactiae: an Italian cohort study

The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Carmen De LucaMarco De Santis

Abstract

Streptococcus agalactiae (Group B streptococcus [GBS]) is the most common cause of sepsis and meningitis in infants <3 months of age. Intrapartum antibiotic prophylaxis (IAP) is effective in preventing the transmission of GBS to newborns. The Centers for Disease Control and Prevention (CDC) guidelines suggest vaginal and rectal cultures to assess GBS colonization between 35 and 37 weeks' gestation. Between July and December 2013, we identified 535 women admitted to the Obstetric and Gynecology Unit of Cardarelli Hospital (Campobasso, Italy) for delivery. We evaluated the indications for IAP, complete execution of IAP, and neonatal outcomes. Our sample included 468 women and 475 live births. Correct screening for GBS was executed in 241 cases (51.5%), the number of women colonized was 96 (30.2%), and 136 women had indications to receive IAP, but only 68 (50%) received adequate treatment. GBS colonization status should be determined by collecting both vaginal and rectal specimens at 35-37 weeks' gestation. Inadequate screening for GBS and incorrect IAP led to an increased incidence of early-onset disease in newborns. Local public health agencies should promote surveillance and educational programs to prevent neonatal GBS infections.

References

Jul 1, 1978·The Journal of Pediatrics·C J Baker
Jun 26, 1986·The New England Journal of Medicine·K M Boyer, S P Gotoff
Apr 1, 1973·The Journal of Pediatrics·G H McCracken
Apr 1, 1973·The Journal of Pediatrics·R A FranciosiR A Zimmerman
Jul 26, 2002·The New England Journal of Medicine·Stephanie J SchragUNKNOWN Active Bacterial Core Surveillance Team
Jan 13, 2004·Journal of Clinical Microbiology·Søren Mose HansenUffe B Skov Sørensen
Sep 4, 2007·Pediatrics·Alberto BerardiUNKNOWN GBS Prevention Working Group of Emilia-Romagna
May 8, 2008·JAMA : the Journal of the American Medical Association·Christina R PharesUNKNOWN Active Bacterial Core surveillance/Emerging Infections Program Network
Sep 20, 2008·The American Journal of Bioethics : AJOB·UNKNOWN Joint Centre for Bioethics Pandemic Ethics Working Group, Ross Upshur
Jun 19, 2009·The New England Journal of Medicine·Melissa K Van DykeStephanie J Schrag
Aug 20, 2011·Journal of Medical Screening·Alberto BerardiUNKNOWN GBS Prevention Working Group, Emilia-Romagna
Aug 28, 2014·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·G C Di RenzoN El Helali

❮ Previous
Next ❯

Citations

Nov 20, 2016·PloS One·Aida BiancoUNKNOWN Collaborative Working Group
Mar 23, 2017·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Teresa W L MaK Y Leung
Sep 7, 2016·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Alberto BerardiFabrizio Ferrari
May 15, 2021·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Kathryn BrayeMaralyn Foureur

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Infectious Diseases in Obstetrics and Gynecology
Sebastian FaroMark Turrentine
JAAPA : Official Journal of the American Academy of Physician Assistants
Kelly Porta, Denise Rizzolo
© 2022 Meta ULC. All rights reserved